Home > Press > Endomagnetics Expands its Horizons
Abstract:
Cambridge company Endomagnetics is receiving enquiries from across the world after it featured on the BBC World Horizons programme recently. The Horizons series features companies and technologies that have the potential to address some of the planet's most pressing challenges. In Endomagnetics' case, they have developed a medical device called SentiMag® based on principles of nano-magnetism, which gives clinicians a much simpler and cheaper method for tracking the spread of cancers, especially breast cancer.
Endomagnetics Expands its Horizons
Cambridge, UK | Posted on April 18th, 2012
As CEO Dr Eric Mayes explained in the video clip, by avoiding the need for radioactive isotopes, the availability of a key technique - sentinel lymph node biopsy - is significantly extended. In some parts of the world, only 5% of the patients who could benefit have access to this technique.
BBC reporter Adam Shaw visited the team in Cambridge as well as filming at Guy's Hospital, London, where he saw a demonstration of how the SentiMag® instrument is used in an operating theatre. Shaw was enthusiastic about nanotechnology and commented: "This could be one technology that's on the wave of what some experts have dubbed the ‘next industrial revolution'".
####
About Endomagnetics
Endomagnetics was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. Endomagnetics is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston.
The company’s first product, the SentiMag®, is an ultrasensitive hand-held probe for tracking injected Sienna+™ nanoscale magnetic materials in the human body. Cambridge, UK-based Endomagnetics is in the process of delivering its technology to global markets. For more information please visit www.endomagnetics.com.
For more information, please click here
Contacts:
Editorial contact:
Terry Nicklin
KeynotePR Ltd
Tel: +44 (0)7923 540695
Company contact:
Dr Eric Mayes
CEO
Endomagnetics Ltd
Tel: +44 (0)1223 437131
Copyright © Endomagnetics
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
You can see the video clip for yourself here:
Videos
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
News and information
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Nanomedicine
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013